Malaysian Genomics introduces its Dtect range of genetic screening in UAE

By Arya M Nair, Official Reporter
  • Follow author on
MGRC introduces Dtect Range in UAE
Representational image

Malaysian Genomics Resource Center (MGRC), a leading genomics and biopharmaceutical specialist, has signed a Strategic Collaboration Agreement (SCA) outlining partnerships to market and distribute its Dtect range of genetic screening services in the UAE.

Other than Malaysian Genomics, the SCA involves American Spine Center (ASC), a Dubai, UAE-based specialist in spinal injury and spine pathology, BALSAM Health Services, Wellness by Design, a nutrition, obesity and weight loss specialist, and Sharjah-based IAC International.

Under the SCA, Malaysian Genomics, ASC, Balsam and Wellness by Design will explore common strategies for joint or allied projects that translate to innovative healthcare tools or solutions, while the role of IAC is to support activities in priority areas, aligning the parties and work with other organizations, where appropriate.

Azri Azerai_Malaysian Genomics launches Dtect Range in UAE
Azri Azerai
Executive Director
Malaysian Genomics

“The SCA will allow us to formally explore how the parties can work together, including technical trials and evaluation of our Dtect screening tests for commercialization in the UAE. Malaysian Genomics’ role will be to provide technical and scientific support under the SCA. In addition, we constantly look for opportunities to partner with like-minded businesses and organizations in expanding our market reach for Dtect and our other services.”

Dr. Hisham Hakim, Chairman of ASC, BALSAM and Wellness by Design, stated that “We welcome this first step in a working relationship with Malaysian Genomics and IAC, and look forward to the inclusion of Dtect to offer more choices to our patients. We are committed to clinical and technological excellence as we bring coordinated patient care with compassion and commitment while ensuring cost efficiency.”

Ms. Nurul Faten Jasmee, CEO of IAC, said that “There are lots of opportunities for the expansion of genetic screening services in the UAE and the wider Middle East and North Africa (MENA) region. We will provide the coordination, business delivery and project management between the parties during the technical trials for Dtect in the UAE, followed by the commercial rollout and expansion throughout the MENA region.”

Related: Abu Dhabi DoH allies with AbbVie to integrate innovation in healthcare